B
PFE icon

Bridgeworth’s Pfizer PFE Stock Holding History

Bridgeworth’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$415K Sell
14,418
-134
-0.9% -$4.05K 0.04% 119
2023
Q3 		$483K Buy
14,552
+989
+7% +$35K 0.05% 96
2023
Q2 		$497K Sell
13,563
-1,431
-10% -$55.7K 0.06% 102
2023
Q1 		$612K Sell
14,994
-406
-3% -$17.5K 0.08% 95
2022
Q4 		$789K Sell
15,400
-135
-0.9% -$6.47K 0.13% 79
2022
Q3 		$680K Sell
15,535
-222
-1% -$10.8K 0.16% 74
2022
Q2 		$826K Buy
15,757
+203
+1% +$10.3K 0.19% 68
2022
Q1 		$805K Sell
15,554
-1,207
-7% -$62.6K 0.19% 69
2021
Q4 		$990K Buy
16,761
+1,439
+9% +$71.3K 0.22% 58
2021
Q3 		$659K Buy
15,322
+666
+5% +$29.5K 0.19% 66
2021
Q2 		$574K Sell
14,656
-957
-6% -$37.2K 0.16% 67
2021
Q1 		$566K Sell
15,613
-604
-4% -$21.4K 0.18% 65
2020
Q4 		$597K Sell
16,217
-1,857
-10% -$68.1K 0.2% 64
2020
Q3 		$629K Sell
18,074
-1,169
-6% -$41K 0.24% 59
2020
Q2 		$597K Sell
19,243
-24
-0.1% -$815 0.23% 62
2020
Q1 		$597K Buy
19,267
+304
+2% +$10.4K 0.27% 54
2019
Q4 		$705K Buy
18,963
+787
+4% +$28K 0.26% 52
2019
Q3 		$620K Sell
18,176
-379
-2% -$13.8K 0.24% 54
2019
Q2 		$763K Buy
18,555
+380
+2% +$15.1K 0.29% 52
2019
Q1 		$732K Sell
18,175
-5,150
-22% -$206K 0.29% 53
2018
Q4 		$810K Sell
23,325
-1,017
-4% -$42.2K 0.46% 35
2018
Q3 		$853K Buy
24,342
+3,699
+18% +$142K 0.47% 35
2018
Q2 		$710K Sell
20,643
-3,833
-16% -$131K 0.31% 50
2018
Q1 		$816K Buy
+24,476
New +$841K 0.37% 44
2017
Q3 		– Sell
-22,082
Closed -$700K – 109
2017
Q2 		$700K Sell
22,082
-3,123
-12% -$98.5K 0.36% 55
2017
Q1 		$814K Buy
25,205
+4,726
+23% +$149K 0.43% 46
2016
Q4 		$640K Buy
+20,479
New +$625K 0.35% 57

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Bridgeworth's PFE Position: Q4 2023 in Review

Bridgeworth reduced its Pfizer (PFE) stake by 0.92% in Q4 2023, selling an estimated $4.05K and leaving 14,418 shares worth $415K. The position accounts for 0.04% of the portfolio, ranked #119.

Bridgeworth first reported a position in PFE in Q4 2016 and has held it in 27 quarters since. The position peaked at $990K in Q4 2021. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

  • Bridgeworth held 14,418 shares of Pfizer worth $415K as of Q4 2023.
  • Bridgeworth sold 134 Pfizer shares in Q4 2023, an estimated $4.05K.
  • Pfizer made up 0.04% of Bridgeworth's portfolio in Q4 2023, its #119 holding.
  • Bridgeworth first reported a position in Pfizer in Q4 2016 and has held it in 27 quarters since.
  • Bridgeworth's Pfizer position peaked at $990K in Q4 2021.
  • 2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Bridgeworth's 13F filing for Q4 2023, filed 26 Jan 2024.